GSK2879552

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for GSK2879552, covering 2019-01-23 to 2019-06-28. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I Dose Escalation Study of GSK2879552 in Subjects With Acute Myeloid Leukemia (AML) [Phase 1]